Specialty chemicals drove strong Q3 and nine-month growth, with EBITDA up 12% and margin at 20.3%. Capacity expansions, new product launches, and a robust outlook for full-year sales and earnings highlight continued momentum, despite FX and energy cost risks.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.